CT Financial Advisors LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 150 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
CT Financial Advisors LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$6,376,000
+5.1%
1,0350.0%0.00%0.0%
Q4 2016$6,065,000
+10.4%
1,0350.0%0.00%
+33.3%
Q3 2016$5,496,000
-19.8%
1,0350.0%0.00%
-25.0%
Q2 2016$6,852,000
+41.7%
1,0350.0%0.00%
+33.3%
Q1 2016$4,834,000
-7.5%
1,0350.0%0.00%0.0%
Q4 2015$5,227,000
+43.5%
1,0350.0%0.00%
+50.0%
Q3 2015$3,643,000
-64.7%
1,0350.0%0.00%
-66.7%
Q2 2015$10,329,000
-55.8%
1,035
-43.6%
0.01%
-53.8%
Q1 2015$23,360,000
-10.0%
1,8350.0%0.01%
-35.0%
Q4 2014$25,965,000
+11.2%
1,8350.0%0.02%
+53.8%
Q1 2014$23,360,0001,8350.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders